第一作者单位:[1]Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Lymphoma, Taiyuan 030032, Peoples R China[2]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lymphoma, Wuhan 430030, Peoples R China
通讯作者:
通讯机构:[1]Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Lymphoma, Taiyuan 030032, Peoples R China[2]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lymphoma, Wuhan 430030, Peoples R China[3]Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan 030032, Peoples R China
推荐引用方式(GB/T 7714):
Liu Hu,Liu Shu-Ying,Zhang Qiao-Hua,et al.Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma[J].ASIAN JOURNAL OF SURGERY.2022,45(6):1301-1302.doi:10.1016/j.asjsur.2022.01.131.
APA:
Liu, Hu,Liu, Shu-Ying,Zhang, Qiao-Hua&Hou, Shu-Ling.(2022).Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma.ASIAN JOURNAL OF SURGERY,45,(6)
MLA:
Liu, Hu,et al."Serum amyloid A and misfolded transthyretin may be the two predictable biomarkers to relapsed/ refractory diffuse large B cell lymphoma".ASIAN JOURNAL OF SURGERY 45..6(2022):1301-1302